What Changed
Price Move History
- Daily moves over 5%
- 36 57 sessions, November 7, 2025 to November 12, 2026
- Largest daily move
- +52.7% close of December 8, 2025
- 1-year change
- +10.3% closing prices, November 7, 2025 to November 12, 2026
- 1-month change
- -27.2% closing prices, October 6, 2026 to November 12, 2026
Company Description
IDenta Corp (IDTA) operates in the professional, scientific, and technical services sector, with a focus on research and development in the physical, engineering, and life sciences (except biotechnology). According to the company’s own descriptions in multiple public announcements, IDenta Corp is a global company engaged in the development and supply of Field Detection and Home Diagnostic Testing Kits for drugs and explosives, as well as unique forensic products serving both homeland security and consumer markets.
The company states that it develops, manufactures and distributes products for both professional law enforcement and security agencies and the retail market. Its products are described as detection and diagnostic kits that are used in field conditions and at home, with applications in narcotics and explosives detection and forensic work. IDenta Corp notes that its products are designed to pass high qualification and testing procedures of law enforcement and security agencies around the world.
Business focus and markets
Based on the company’s public communications, IDenta Corp positions itself around two main market areas:
- Homeland security markets, where field detection kits and forensic products are used by professional law, security and related agencies.
- Consumer and retail markets, where home diagnostic testing kits and related products are offered through retail channels.
The company has highlighted activities with U.S. government customers and retail markets for fentanyl detection solutions, and has referred to expanding operations in the U.S. market through local distributors and participation in trade shows. In its communications, IDenta Corp also mentions distributors in various territories and an expanding global presence.
Detection technologies and product themes
In its news releases, IDenta Corp repeatedly emphasizes its work on rapid, accurate field-testing solutions for narcotics and explosives. The company has also reported adding a variety of products to identify fentanyl and derivatives, describing these as devices that offer quick, on-the-spot testing for a variety of drugs, including fentanyl. These fentanyl-related products are described as being particularly useful for law enforcement agencies, border control, and workplace drug testing.
The company characterizes some of its offerings as revolutionary products that are developed, manufactured and distributed under its own control. It also notes that its products consistently pass demanding qualification and testing procedures required by law enforcement and security agencies.
Operational themes and strategy as described by the company
Across several years of financial and operational updates, IDenta Corp has described a number of recurring themes:
- Market expansion: The company has reported expanding operations in the U.S. market and adding new distributors in previously untapped territories. It has also referred to broadening its market presence and entering new markets via distributors.
- Customer focus: IDenta Corp attributes some of its reported financial improvements to strong customer satisfaction and efforts to create marketing material, including videos, to demonstrate product simplicity.
- Production efficiency: The company has described investments in upgrading and optimizing its production line, managing employees, and improving operational efficiency, and has linked these efforts to changes in gross profit and net profit in its annual and quarterly reports.
- Trade shows and exposure: IDenta Corp has reported participating in multiple trade shows for both government and retail markets, particularly in the U.S., and has stated that exposure of its products in that market has been significant.
Financial reporting highlights (structural, not numeric)
In a series of press releases covering annual and quarterly financial statements, IDenta Corp has reported on revenues, gross profit, operating profit, net profit, and cash and cash equivalents. The company has linked changes in these measures to factors such as:
- Optimization of the production line and management of employees.
- Participation in trade shows and marketing activities.
- Expansion into new markets via distributors.
- Introduction of new product lines with higher profit margins.
- Investments in marketing and sales, particularly in the U.S. market.
These communications indicate that IDenta Corp regularly publishes financial updates and commentary on its operational performance, while emphasizing growth in sales, profitability, and cash position over various periods.
Corporate events and shareholder communications
IDenta Corp has announced shareholder meetings and has referenced potential changes in the company’s structure subject to approval by its board of directors and shareholders. The company has used online meeting formats to allow participation from different locations. These announcements underscore an ongoing effort to communicate with shareholders about corporate governance and structural considerations, although specific outcomes of such proposals are not detailed in the provided information.
Position within its sector
Within the broader category of professional, scientific, and technical services, and specifically research and development in the physical, engineering, and life sciences (except biotechnology), IDenta Corp’s own descriptions place it in a niche focused on field detection, home diagnostics, and forensic testing kits for drugs and explosives. Its emphasis on homeland security applications, consumer markets, and fentanyl detection solutions distinguishes its stated focus from more general research and development activities.
Stock Performance
IDenta (IDTA) closed at $0.2300 on November 12, 2026. Over the past 12 months, the price has gained 10.3%.
IDTA Metrics & Rankings
Price returns through November 12, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
IDenta has 10 recent news articles, with the latest published on . Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all IDTA news →
SEC Filings
Short Interest History
Days to Cover History
IDTA Company Profile & Sector Positioning
IDenta (IDTA) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing IDTA often look at related companies in the same sector, including Immunovia AB (IMMVF), InVitro Intl (IVRO), Hypha Labs, Inc. (FUNI), NovelStem Intl Corp (NSTM), and Telo Genomics Corp (TDSGF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IDTA's relative position within its industry.